Published December, 2015
By Ena Wang, Paolo A. Ascierto and David F. Stroncek
Publisher: Springer (Birkhauser Verlag AG)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Ena Wang, Paolo A. Ascierto and David F. Stroncek
Publisher: Springer (Birkhauser Verlag AG)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents.
Hardback
€170.79
Published June, 2015
By Nicola Curtin, Ricky Sharma, Nicola J. Curtin and Ricky A. Sharma
Publisher: Springer (Birkhauser Verlag AG)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Nicola Curtin, Ricky Sharma, Nicola J. Curtin and Ricky A. Sharma
Publisher: Springer (Birkhauser Verlag AG)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. PARP plays a pivotal role in DNA repair and may contribute to the therapeutic resistance to DNA damaging agents used to treat cancer.
Hardback
€182.99
Published June, 2015
By Jorge J. Castillo and Peter J. Quesenberry
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Jorge J. Castillo and Peter J. Quesenberry
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
This book will be the first that focuses on solely on model organisms for lymphoma. It's editors are internationally recognized in the field.
Paperback / softback
€146.39
€182.99
Published January, 2015
By Moulay A. Alaoui-Jamali, Lawrence C. Panasci, Raquel Aloyz, Lawrence Panasci and Moulay Alaoui-Jamali
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Moulay A. Alaoui-Jamali, Lawrence C. Panasci, Raquel Aloyz, Lawrence Panasci and Moulay Alaoui-Jamali
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
A comprehensive review of the recent developments in DNA repair research that have potential for translational applications.
Paperback / softback
€158.59
€243.99
Published January, 2015
By Gail Lewis Phillips
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Gail Lewis Phillips
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.
Paperback / softback
€146.39
€195.19
Published December, 2014
By Frank E. Koehn
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Frank E. Koehn
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
With reliable commentary and analysis in a sector often associated with outlandish claims, this volume provides a valuable overview of how natural products could generate new cancer therapeutics as well as mitigating the deleterious effects of chemotherapy.
Paperback / softback
€146.39
€182.99
Published November, 2014
By Beverly A. Teicher
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Beverly A. Teicher
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
The past 6 years since the first edition of this book have seen great progress in the development of genetically engineered mouse (GEM) models of cancer.
Paperback / softback
€219.59
€268.39
Published November, 2014
By Gary J. Kelloff, Ernest T. Hawk and Caroline C. Sigman
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Gary J. Kelloff, Ernest T. Hawk and Caroline C. Sigman
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
Despite significant advances in cancer treatment and measures of neoplastic progression, drug effect (or early detection, overall cancer incidence has increased, pharmacodynamic markers), and markers that measure cancer-associated morbidity is considerable, and overall prognosis as well as predict responses to specific therapy.
Paperback / softback
€304.99
Published November, 2014
By Gary K Schwartz
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Gary K Schwartz
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer.
Paperback / softback
€182.99
Published November, 2014
By Ryan J. Sullivan
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
By Ryan J. Sullivan
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available
This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma.
Hardback
€158.59